2024-11-18 08:39:48
Innovent Announced Clinical Data of Multiple Trials Will be Presented at the 2022 ESMO-IO and ASH Annual Meetings
Corporate/ 2023-07-24
Innovent Announced Clinical Data of Mult...

ROCKVILLE,Md. and SUZHOU,China,Nov. 28,2022-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical c...

Lyvgen Announces Phase 2 Clinical Collaboration with Bristol Myers Squibb to Evaluate LVGN7409 in Combination with Nivolumab in Non-Small Cell Lung Cancer Patients
Health/ 2023-07-22
Lyvgen Announces Phase 2 Clinical Collab...

LVGN7409 is a next generation CD40 agonistic antibody; Nivolumab is a PD-1 checkpoint inhibitor; docetaxel is an anti-tubulin chemotherapy a...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release